For the last decade, Dr. David Eifrig and I have been on the same page. We've both been among the most consistently bullish Stansberry Research analysts over the past 10 years...
This advertisement is from DailyWealth, a free e-letter.
You can unsubscribe here but you will no longer receive DailyWealth.
Daily Wealth

Dear Reader,

For the last decade, Dr. David Eifrig and I have been on the same page.

We've both been among the most consistently bullish Stansberry Research analysts over the past 10 years.

Now, we have different approaches to finding attractive investment opportunities.

But in retrospect, we've been following a very similar script for most of this bull market.

Coincidentally... We both became bullish on gold recently – something Doc has never recommended before other than as a chaos hedge.

It's part of the reason why I've been urging my readers to consider attending the Urgent Market Briefing Dr. Eifrig is holding this Wednesday.

I have a tremendous amount of respect for Doc's work ethic and integrity.

He hates fearmongering...

And I've never once seen him urge people to get into a "hot" investment.

So, his caution today is something to take note of.

He's invited all my readers to hear what market signals are currently troubling him.

And he'll share his recommendations for what you can do about it today.

Attendance is free. But you'll need to reserve a spot.

Do so by clicking here.

Regards,

Dr. Steve Sjuggerud
Editor, DailyWealth




All contents of this e-mail are copyright 2019 by Stansberry Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Porter Stansberry. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines.

DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Stansberry Research.

You're receiving this email at newsletter@newslettercollector.com. If you have any questions about your subscription, or would like to change your email settings, please contact Stansberry Research at (888) 261-2693 Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Or if calling internationally, please call 443-839-0986. Stansberry Research, 1125 N Charles Street Baltimore, MD 21201. If you wish to contact us by email, please do not reply to this message but instead go to info@stansberrycustomerservice.com.

To unsubscribe from this mailing, click here: Unsubscribe